Pharmacopoeia is a national standard system for the production and quality management of various drugs, medical devices and health care products, aiming at ensuring the quality and safety of related products. Each edition of Pharmacopoeia will be revised and updated according to the development of the times and technological progress. The 2020 edition of Pharmacopoeia was officially implemented in June 5438+February 65438+May 2020. There are many revisions in this version, involving products in many fields, including medicines, health foods, medical devices, biological products and so on. The revision mainly includes adding and modifying drug quality standards, optimizing analysis methods and increasing the detection of pollutants in products. The implementation of this revised Pharmacopoeia will improve the quality and safety level of drugs, health care products and other products in China, and promote the development of health undertakings and healthy market.
How to inquire whether the related drugs conform to the 2020 Pharmacopoeia? The public can check whether the relevant drugs meet the requirements of the 2020 Pharmacopoeia through channels such as official website and official website of the State Administration of Pharmaceutical Products and major pharmaceutical manufacturers. It should be reminded that the public should follow the doctor's advice and follow the correct method of medication.
The 2020 edition of Pharmacopoeia has been implemented since June 65438+February 65438+May 2020, covering the product quality standards in many fields such as medicine and health food in China. After this revision, it will effectively improve the quality and safety level of related products and promote the development of health undertakings and the healthy development of the market. When using related drugs, citizens should follow the doctor's advice and pay attention to inquire whether the products meet the relevant specifications.
Legal basis:
"Drug Administration Law of People's Republic of China (PRC)" Article 32 The drug supervision and administration department of the State Council shall formulate and revise the quality standards for drugs, medicinal materials and drug additives.